NIPT Stream Log

"Mark Brewer summarises his initiation report on Premaitha, a molecular diagnostics company that has developed and launched a non-invasive prenatal test (NIPT), targeted initially at ex-US markets. He explains how the company is primarily products-based, addressing the needs of its laboratory customers, and how it is differentiated from other NIPTs by a faster turnaround time, a reduced need to re-run tests (failure rate), the fact that the test is CE marked and that it matches the specifications of National screening programmes. He believes Premaitha is well placed to capitalise on an addressable market worth $7.5-20.0bn. First-year revenues of c£2.5m are indicative of early traction in a European market that is underpenetrated compared with the US (c1.4% vs 25%)." Note from finnCap on Research Tree

finnCap's note from this morning: "Premaitha is a molecular diagnostics company that has developed and launched a non-invasive prenatal test (NIPT), targeted initially at ex-US markets; the company is primarily products-based, addressing the needs of its laboratory customers. Differentiated from other NIPTs by a faster turnaround time, a reduced need to re-run tests (failure rate), the fact that the test is CE marked and that it matches the specifications of National screening programmes, Premaitha is well placed to capitalise on an addressable market worth $7.5-20.0bn. First-year revenues of c£2.5m are indicative of early traction in a European market that is underpenetrated compared with the US (c1.4% vs 25%). We..." From Research Tree

shorters and day traders could get caught out here very risky sure a huge rns coming very soon then boooooom

contract rns before end of month?

traders will all jump back in soon getting twitchy

keep it up until rns strikes

keep up the good work

anyone who thinks this is going below 24p is a bit silly

oh dear the rampers are slowly coming to this BB come back Ian we need you

relax